Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer’s disease

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149

Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease

Zuo, X., & Jia, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.034 · Cited by 28

Phenolic contents and biological activities of Limoniastrum guyonianum fractions obtained by Centrifugal Partition Chromatography

Trabelsi, N., Oueslati, S., Henry-Vitrac, C., Waffo‐Téguo, P., Medini, F., Mérillon, J., Abdelly, C., & Ksouri, R. (2013) · Industrial Crops and Products · doi:10.1016/j.indcrop.2013.06.011 · Cited by 28

Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task

Moreira, T. J., Malec, E., Östenson, C.-G., Efendić, S., & Liljequist, S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.034 · Cited by 29

Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population

Xue, S., Jia, L., & Jia, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.002 · Cited by 27

Characterization of the interaction between Aβ 1–42 and glyceraldehyde phosphodehydrogenase

Verdier, Y., Földi, I., Sergeant, N., Fülöp, L., Penke, Z., Janáky, T., Szűcs, M., & Penke, B. (2008) · Journal of Peptide Science · doi:10.1002/psc.998 · Cited by 27

Constitutively Active Akt Inhibits Trafficking of Amyloid Precursor Protein and Amyloid Precursor Protein Metabolites through Feedback Inhibition of Phosphoinositide 3-Kinase

Shineman, D. W., Dain, A. S., Kim, M. L., & Lee, V. M. ‐. (2009) · Biochemistry · doi:10.1021/bi802070j · Cited by 26

Fecal Microbiota Transplantation in Alzheimer’s Disease: Mechanistic Insights Through the Microbiota–Gut–Brain Axis and Therapeutic Prospects

Ren, J., Wang, Q., Hong, H., & Tang, C. (2025) · Microorganisms · doi:10.3390/microorganisms13081956 · Cited by 28

Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population

Song, J., Yu, J., Liu, M., Yan, C., & Tan, L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.09.008 · Cited by 25

Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review

Sabayan, B., Foroughinia, F., Mowla, A., & Borhani‐Haghighi, A. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507312623 · Cited by 24

β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling

Liu, W., Sun, F.-X., Wan, M., Jiang, F., Xiangyu, B. O., Lin, L., Tang, H., & Xu, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00969 · Cited by 24

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease

Flieger, J., Forma, A., Flieger, W., Flieger, M., Gawlik, P. J., Dzierżyński, E., Maciejewski, R., Teresiński, G., & Baj, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168982 · Cited by 30

Insulin signaling in Drosophila melanogaster mediates Aβ toxicity

Huang, Y., Wan, Z., Wang, Z., & Zhou, B. (2018) · Communications Biology · doi:10.1038/s42003-018-0253-x · Cited by 23

Cognitive and motor perturbations in elderly with longstanding diabetes mellitus

Díaz-Gerevini, G. T., Repossi, G., Daín, A., Tarrés, M. C., Das, U. N., & Eynard, A. R. (2013) · Nutrition · doi:10.1016/j.nut.2013.11.007 · Cited by 26

A highly sensitive peptide substrate for detecting two Aβ-degrading enzymes: Neprilysin and insulin-degrading enzyme

Chen, P., Liao, T., Hu, C., Wu, S.-T., Wang, S. S. ‐., & Chen, R. P. ‐. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.04.024 · Cited by 21

Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular modelling approach

Mohammed, A. A., Barale, S. S., Kamble, S. A., Paymal, S. B., & Sonawane, K. D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124880 · Cited by 21

Role of Amyloid-β–Metal Interactions In Alzheimer‘s Disease

Duce, J. A., Bush, A. I., & Adlard, P. A. (2011) · Future Neurology · doi:10.2217/fnl.11.43 · Cited by 20

A Proline-Rich Polypeptide from Ovine Colostrum: Colostrinin with Immunomodulatory Activity

Zimecki, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-74087-4_9 · Cited by 19

Unveiling the Effects of Copper Ions in the Aggregation of Amyloidogenic Proteins

Oliveri, V. (2023) · Molecules · doi:10.3390/molecules28186446 · Cited by 21

Neurodegenerative Diseases: Pathology and the Advantage of Single-Cell Profiling

Galvin, J. E. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023592.53769.4d · Cited by 18

Cytosolic amyloid-β peptide 42 escaping from degradation induces cell death

Lee, E. K., Park, Y. W., Shin, D. Y., Mook‐Jung, I., & Yoo, Y. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.166 · Cited by 19

11C-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo

Nordeman, P., Estrada, S., Odell, L. R., Larhed, M., & Antoni, G. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.03.024 · Cited by 17

Studies on the interaction between vanillin and β-Amyloid protein via fluorescence spectroscopy and atomic force microscopy

Song, S., Ma, X., Zhou, Y., Xu, M., Shuang, S., & Dong, C. (2016) · Chemical Research in Chinese Universities · doi:10.1007/s40242-016-5347-8 · Cited by 17

Amyloid-Beta-Activated Human Microglial Cells Through ER-Resident Proteins

Yoo, Y., Byun, K., Kang, T., Bayarsaikhan, D., Kim, J. Y., Oh, S., Kim, Y. H., Kim, S. Y., Chung, W., Kim, S. U., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr500926r · Cited by 17

The Amyloid β Protein

Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18

Destabilization of the Alzheimer’s amyloid-β protofibrils by THC: A molecular dynamics simulation study

Kanchi, P. K., & Dasmahapatra, A. K. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.107889 · Cited by 16

Zinc Deficiency

Sauer, A. K., Hagmeyer, S., & Grabrucker, A. M. (2016) · InTech eBooks · doi:10.5772/63203 · Cited by 16

Neuroprotective role of estrogens relationship with insulin IGF-1 signaling

González, C. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e403 · Cited by 15

Cytoprotective Effects of Phaeophyta Extracts from the Coast of Jeju Island in HT-22 Mouse Neuronal Cells

Shin, D., Han, E.-H., & Park, S. (2014) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2014.43.2.224 · Cited by 15

An impedimetric micro-immunosensing assay to detect Alzheimer's disease biomarker: Aβ40

Zakaria, N., Ramli, M. Z., Ramasamy, K., Meng, L. S., Yean, C. Y., Singh, K. K. B., Zain, Z. M., & Low, K.-F. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.05.031 · Cited by 15

Metallopeptides — from Drug Discovery to Catalysis

Ming, L. (2010) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201000043 · Cited by 14

PSEN1 gene polymorphisms in Caucasian Alzheimer's disease: A meta-analysis

Veerabathiran, R., Husain, R. S. A., & Ahmed, S. S. S. J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.016 · Cited by 13

Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol

Çalan, Ö. G., Akan, P., Cataler, A., Dogan, C., & Koçtürk, S. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1886-0 · Cited by 14

A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: Identifying the receptors involved in amyloid β degradation

Yang, J., Fan, W., Rogers, C., Chatterton, J. E., Bliesath, J. R., Liu, G., Ning, K., Wang, C., Rhoades, K. L., Wong‐Staal, F., et al. (2006) · Genomics · doi:10.1016/j.ygeno.2006.03.010 · Cited by 14

Measurement of Altered AβPP Isoform Expression in Frontal Cortex of Patients with Alzheimer's Disease by Absolute Quantification Real-Time PCR

Tharp, W. G., Lee, Y., Greene, S. M., Vincellete, E., Beach, T. G., & Pratley, R. E. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111337 · Cited by 13

Hereditary and sporadic beta-amyloidoses

Fede, G. D. (2013) · Frontiers in bioscience · doi:10.2741/4173 · Cited by 13

BACE1 Gene Promoter is Differentially Regulated: Detection of a Novel Promoter Region for Its Cell Type-Specific Regulation

Lahiri, D. K., Maloney, B., & Ge, Y. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:2:193 · Cited by 13

The action of phosphodiesterase-5 inhibitors on β-amyloid pathology and cognition in experimental Alzheimer's disease: A systematic review

Justo, A. F. O., Toscano, E. C. D. B., Farias‐Itao, D. S., & Suemoto, C. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121570 · Cited by 12

The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation

Galzitskaya, O. V., Grishin, S. Y., Glyakina, A. V., Dovidchenko, N. V., Konstantinova, A. V., Kravchenko, S. V., & Surin, A. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043781 · Cited by 12

Comparative binding analysis of WGX50 and Alpha-M with APP family proteins APLP1 and APLP2 using structural-dynamics and free energy calculation approaches

Ali, A., Masood, A., Khan, A. A., Zhu, F.-Y., Cheema, M. A. R., Samad, A., Wadood, A., Khan, A., Yu, Q., Heng, W., et al. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp06083c · Cited by 11

Les aspects génétiques de la maladie d’Alzheimer (Revue)

Kadmiri, N. E., Hamzi, K., Moutawakil, B. E., Slassi, I., & Nadifi, S. (2013) · Pathologie Biologie · doi:10.1016/j.patbio.2013.04.001 · Cited by 20

The genetic association between alpha-2-macroglobulin (A 2 M) gene deletion polymorphism and low serum A 2 M concentration in overweight/obese Thais

RUGSARASH, W., Tungtrongchitr, R., Petmitr, S., Phonrat, B., Pongpaew, P., Harnroongroj, T., & Tungtrongchitr, A. (2006) · Nutritional Neuroscience · doi:10.1080/10284150600771777 · Cited by 10

Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis

Cheng, H., Wang, L., Shi, T., Shang, Y., & Jiang, L. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.941440 · Cited by 10

Diverse role of S100 calcium-binding protein B in alzheimer’s disease: pathological mechanisms and therapeutic implications

Sarkar, S., Porel, P., Kosey, S., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01697-y · Cited by 9

A Proteomic Approach for the Involvement of the GAPDH in Alzheimer Disease in the Blood of Moroccan FAD Cases

Kadmiri, N. E., Cuardos, R., Moutawakil, B. E., Slassi, I., Ávila, J., Nadifi, S., Hachem, A., & Soukri, A. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0374-8 · Cited by 9

Platelets and Neurodegenerative Diseases

Donner, L., & Elvers, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_81 · Cited by 7

Protein Misfolding and Aggregation of Tau Protein in Alzheimer’s Disease

Chandrashekar, M., & Chinnathambi, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2063-1_8 · Cited by 8

A Review on the Use of Modern Computational Methods in Alzheimer’s Disease-Detection and Prediction

De, A., Mishra, T. K., Saraf, S., Tripathy, B. K., & Reddy, S. S. (2023) · Current Alzheimer Research · doi:10.2174/0115672050301514240307071217 · Cited by 8

Insulin deprivation decreases insulin degrading enzyme levels in primary cultured cortical neurons and in the cerebral cortex of rats with streptozotocin-induced diabetes

Kazkayası, İ., Burul-Bozkurt, N., Ismail, M.-A.-M., Merino‐Serrais, P., Pekiner, C., Cedazo-Mı́nguez, Á., & Uma, S. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.01.008 · Cited by 8

Interaction between baicalein and amyloid-β fibrils studied by fluorescence spectroscopy

Song, S., Wang, Y., Xiong, L.-M., Qu, L., & Xu, M. (2013) · Chemical Research in Chinese Universities · doi:10.1007/s40242-013-2180-1 · Cited by 8

Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment

Soria-Tobar, L., Román-Valero, L., Sebastián‐Serrano, Á., Aivar, P., Alvarez‐Castelao, B., & Dı́az-Hernández, M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01600-x · Cited by 8

Metal Ions and Alzheimer's Disease

Adlard, P. A., & Bush, A. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_15 · Cited by 6

Association of PSEN1 rs165932 polymorphism with Alzheimer's disease susceptibility: An extensive meta-analysis

Husain, R. S. A., Subramaniyan, K., Ahmed, S. S. S. J., & Veerabathiran, R. (2018) · Meta Gene · doi:10.1016/j.mgene.2018.11.007 · Cited by 7

In vitro characterization of a γ‐secretase radiotracer in mammalian brain

Patel, S., O'Malley, S. S., Connolly, B., Liu, W., Hargreaves, R. J., Sur, C., & Gibson, R. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03525.x · Cited by 7

AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma

Provenzano, M. J., Yu, L., Hitchler, M. J., Fitzgerald, M. P., Robinson, R. A., Wayne, S., Meer, M. V., & Domann, F. E. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.06.001 · Cited by 7

Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder

Wang, Y., Liu, X., Liu, D., Cheng, M., Zhao, N., He, M., & Zhang, X. (2021) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202000058 · Cited by 6

Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools

Stanciu, G. D., Ababei, D. C., Rusu, R.-N., Bild, V., & Tamba, B.-I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061270 · Cited by 6

[Osthole suppresses amyloid precursor protein expression by up-regulating miRNA-101a-3p in Alzheimer's disease cell model].

Lin, Y., Yao, Y., Liang, X., Shi, Y., Kong, L., Xiao, H., Wu, Y., Ni, Y., & Yang, J. (2018) · PubMed Central · doi:10.3785/j.issn.1008-9292.2018.10.05 · Cited by 6

GAPDH: β-Amyloid Mediated Iron Accumulation in Alzheimer’s Disease: A New Paradigm for Oxidative Stress Induction in Neurodegenerative Disorders

Sirover, M. A. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_4 · Cited by 6

Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease

Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5

Evidence for the Control of Aggrecanases by Insulin and Glucose in Alzheimer's Disease

Akyol, S., Uğurcu, V., Çakmak, Ö., Altuntaş, A., Yükselten, Y., Akyol, Ö., Sunguroğlu, A., & Demircan, K. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140905124459 · Cited by 5

Measurement of altered APP isoform expression in adipose tissue of diet-induced obese mice by absolute quantitative real-time PCR

Min, H., Kim, J.-I., Kim, Y., Yoon, M.-S., Pratley, R. E., & Lee, Y. (2017) · Animal Cells and Systems · doi:10.1080/19768354.2017.1290679 · Cited by 5

Essential Metals in the Brain and the Application of Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry for their Detection

Folarin, O. R., Olopade, F. E., & Olopade, J. O. (2021) · Nigerian Journal of Physiological Sciences · doi:10.54548/njps.v36i2.1 · Cited by 5

Case report: Double mutations in a patient with early-onset Alzheimer’s disease in China, PSEN2 and IDE variants

Chang, Z., Wang, Z., Luo, L., Xie, Z., Yue, C., Bian, X., Yang, H., & Wang, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1423892 · Cited by 4

Amyloidogenic proteolysis of APP regulates glutamatergic presynaptic functionPreprint

Kapadia, A., Schuhmann, F., Daşkın, E., Walter, J., Lindahl, I., Rahmani, N., Pezeshkian, W., & Hafner, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.01.667924 · Cited by 4

Distribution of LIM domain kinase 1 in the olfactory bulb, cerebral cortex, hippocampus, and cerebellum of the App/PS+/- mice

An, L., Liu, J., Li, W., Shi, Y. J., Lin, X. H., Yu, D. M., Deng, J., & Ren, X. Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.16.24 · Cited by 3

Lentivirus-mediated APP695-RNAi reduces apoptosis in APP transgenic mouse neurons

Zhao, X., Wen, L., Li, G., Ba, Q., Cui, Y., Han, Z., Jia, Y., & Xu, Y. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834b6c92 · Cited by 3

pH modulates amyloid- β 42 conformation in lipid membranes: evidence from circular dichroism, Raman spectroscopy, and molecular dynamics simulations

Abdeljawaad, K. A. A., Arynbek, Y., Маматкулов, К. З., Le, H., Ibrahim, M. A. A., Mekhemer, G. A. H., & Arzumanyan, G. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2572296 · Cited by 2

Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)

Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 5

Progress on Aβ-Targeted Therapeutic Strategies for Alzheimer′s Disease*

Hua, Q., Ding, H., & Liang, M. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00215 · Cited by 2

Calcium ions do not influence the Aβ(25–35) triggered morphological changes of lipid membranes

Kurakin, S., Ivankov, O. I., Dushanov, E., Murugova, T. N., Ermakova, E. V., Vladimirovich, E. S., Mukhametzyanov, T. A., Smerdova, S., Klochkov, V. V., Kuklin, A. I., et al. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107292 · Cited by 2

Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes

Nedjadi, T., Haque, A., Alam, Q., Gan, S. H., Chaudhary, A., Abuzenadah, A. M., Damanhouri, G. A., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660140 · Cited by 2

Amyloidogenecity and pitrilysin sensitivity of a lysine-free derivative of amyloid β-peptide cleaved from a recombinant fusion protein

Cornista, J. C., Koga, Y., Takano, K., & Kanaya, S. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.09.003 · Cited by 2

Neuroprotective Role of Statins in Alzheimer's Disease: Anti-Apoptotic Signaling

Hunt, W. T., Salins, P. B., Anderson, C. M., & Amara, F. (2010) · The Open Neuroscience Journal · Cited by 2

Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2

Memory-Enhancing and Antioxidant Activities of the Hydroethanolic Leave Extract of Piliostigma reticulatum (Fabaceae) in the Monosodium Glutamate-Induced Alzheimer's Disease Model

Beppe, G. J., Barga, B. M., Atsamo, A. D., Fedaski, C.-R., Folefack, A. I., Allah-Doum, N. G., Franklin, Z. G., & Dongmo, A. B. (2023) · The Journal of Phytopharmacology · doi:10.31254/phyto.2023.12101 · Cited by 2

Can we put Humpty Dumpty back together again? What does protein quantification mean in bottom-up proteomics?Preprint

Plubell, D. L., Käll, L., Webb‐Robertson, B., Bramer, L., Ives, A. N., Kelleher, N. L., Smith, L. M., Montine, T. J., Wu, C. C., & MacCoss, M. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.25.428175 · Cited by 2

Implication de l'acide docosanoïque (C22 0) et des acides gras à très longue chaîne (acide tétracosanoïque (C24 0), acide hexacosanoïque ( C26 0) dans la maladie d'Alzheimer : aspects biologiques et cliniques

Zarrouk, A. (2013) · theses.fr (ABES) · doi:10.70675/0ca0afb8z8b2cz4b48zb97az382f4a6003ba · Cited by 2

Early-Onset Alzheimer’s disease and amyloid precursor protein gene mutations

Varte, V., Ralte, L., & Kumar, N. S. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00203-y · Cited by 7

Unraveling the metabolic potential of Moringa oleifera derived metabolites in combating Parkinson's and Alzheimer's disease

Haider, S. Z., Iqbal, M. J., Sun, X., Alghamdi, H. A., Yuan, Q., Zhu, D., & Nawaz, M. Z. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109442 · Cited by 1

Single-cell RNA sequencing reveals disease associated changes in brain endothelial cells in the 5XFAD mouse

Embalabala, R., Masters, H., Ziehm, E. M., Pouncey, J., Kim, H., & Lippmann, E. S. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00766-w · Cited by 1

Presynaptic accumulation of APP-CTFβ may contribute to synaptic dysfunction in Alzheimer’s disease

Kapadia, A., Schuhmann, F., Daşkın, E., Walter, J., Lindahl, I., Rahmani, N., Morrema, T. H. J., Rozemüller, A. J. M., Boon, B. D. C., Pezeshkian, W., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00899-6 · Cited by 1

Canine counterpart of senile dementia of the Alzheimer type

Rofina, J., Eerdenburg, F. J. C. M. V., & Gruys, E. (2007) · Utrecht University Repository (Utrecht University) · Cited by 1

Neuroprotective Role of Statins in Alzheimer`s Disease: Anti-Apoptotic Signaling~!2009-02-06~!2010-04-04~!2010-06-22~!

Hunt, W. T., Salins, P. B., Anderson, C. M., & Amara, F. (2010) · The Open Neuroscience Journal · doi:10.2174/1874082001004010013 · Cited by 1

Single-Molecule Studies of Amyloidogenic Proteins

Kellermayer, M., Karsai, Á., Murvai, Ü., Erdélyi‐Bótor, S., Kardos, J., & Pires, R. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4921-8_7 · Cited by 1

Copper and Alzheimer Disease: The Good, the Bad and the Ugly

Hung, Y. H., Bush, A. I., & Cherny, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_30 · Cited by 1

Identification and Functional Characterization of Genetic Risk Factors in Alzheimer´s Disease

Eckart, K. (2009) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10259 · Cited by 1

Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model

Zhang, P. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6752 · Cited by 1

Monomeric states of the beta-amyloid peptide investigated under high pressure by nuclear magnetic resonance spectroscopy

Cavini, Í. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2019.tde-07052019-102916 · Cited by 1

The novel role of the neuropeptides orexin and QRFP and their involvement in Alzheimer's disease

Davies, J. (2014) · Brunel University Research Archive (BURA) (Brunel University London)

Variable expressions of ADAM family genes in tissues and cancer cells

Kleino, I. (2007) · Tampere University Institutional Repository (Tampere University)

Recombinant AAV gene therapy and delivery for Alzheimer's disease

Carty, N. (2009)

Funktionelle Charakterisierung der synaptischen Transmission in APP/APLP1/APLP2-defizienten Mäusen

Kaufmann, S. G. (2006) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-686

INTERACTIONS OF CHOLINERGIC INNERVATION AND SOLUBLE AB42 PEPTIDE METABOLISM IN THE HIPPOCAMPUS

Isanski, B. A. (2007) · D-Scholarship@Pitt (University of Pittsburgh)

Tau and neurofilament proteins in Alzheimer's disease and related cell models

Björkdahl, C. (2007) · Figshare

Effects of A-beta immunotherapy and Omega-3 fatty acid administration in Alzheimer's transgenic mice

Jensen, M. (2006)

Metalloproteins and Metallopeptides – Natural Metallofoldamers

Lykourinou, V., & Ming, L. (2013) · doi:10.1002/9781118517413.ch1

The a₁-antichymotrypsin-51bp promoter polymorphism : functional activity and its role in Alzheimer's disease

Ritchie, A. (2004) · Nottingham ePrints (University of Nottingham)

Investigations into the interaction between the beta-secretase protein BACE1 and a member of the reticulon family, RTN3

Weber, C. (2010) · University of Vienna · doi:10.25365/thesis.8628

INTRACELLULAR DYNAMICS OF ALZHEIMER DISEASE-RELATED PROTEINS

Selivanova, A. V. (2007) · Figshare

The involvement of degradation pathways and neuron-to-neuron transmission in Alzheimer’s disease

Agholme, L. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Proteolytic processing of Alzheimer’s β‐amyloid precursor protein

Zhang, H., Ma, Q., Zhang, Y., & Xu, H. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07519.x · Cited by 344

Amyloid Precursor Protein Processing and Alzheimer's Disease

O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061

Proteolytic Processing of the Amyloid Precursor Protein of Alzheimer’s Disease

Lichtenthaler, S. F., Masters, C. L., & Beyreuther, K. T. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_19 · Cited by 2

Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review

Yuksel, M., & Tacal, Ö. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172415 · Cited by 99

The role of APP in Alzheimer’s disease

Pung, L., Wang, X., Li, M., & Xue, L. (2013) · Advances in Alzheimer s Disease · doi:10.4236/aad.2013.22008 · Cited by 4